Samrat Pharmachem standalone net profit declines 67.44% in the December 2022 quarter
Sales rise 51.77% to Rs 83.99 crore
Net profit of Samrat Pharmachem declined 67.44% to Rs 2.10 crore in the quarter ended December 2022 as against Rs 6.45 crore during the previous quarter ended December 2021. Sales rose 51.77% to Rs 83.99 crore in the quarter ended December 2022 as against Rs 55.34 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales83.9955.34 52 OPM %4.0715.58 -PBDT2.948.72 -66 PBT2.788.57 -68 NP2.106.45 -67Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content